Our top pick for
Aurora Cannabis Inc (ACB) is a leading drug manufacturers-specialty & generic business based in the US. It opened the day at $7.46 after a previous close of $7.44. During the day the price has varied from a low of $7.34 to a high of $7.74. The latest price was $7.39 (25 minute delay). Aurora Cannabis is listed on the NASDAQ and employs 1,761 staff. All prices are listed in US Dollars.
|52-week range||$3.71 - $18.98|
|50-day moving average||$6.86|
|200-day moving average||$7.85|
|Wall St. target price||$7.32|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.31|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||2.50%|
|1 month (2021-09-16)||11.63%|
|3 months (2021-07-19)||4.97%|
|6 months (2021-04-19)||-9.77%|
|1 year (2020-10-19)||56.90%|
|2 years (2019-10-18)||100.82%|
|3 years (2018-10-19)||9.9658|
|5 years (2016-10-19)||350.83%|
|Revenue TTM||$245.3 million|
|Gross profit TTM||$-21,558,000|
|Return on assets TTM||-6.43%|
|Return on equity TTM||-33.33%|
|Market capitalisation||$1.4 billion|
TTM: trailing 12 months
There are currently 40.4 million Aurora Cannabis shares held short by investors – that's known as Aurora Cannabis's "short interest". This figure is 5.5% up from 38.3 million last month.
There are a few different ways that this level of interest in shorting Aurora Cannabis shares can be evaluated.
Aurora Cannabis's "short interest ratio" (SIR) is the quantity of Aurora Cannabis shares currently shorted divided by the average quantity of Aurora Cannabis shares traded daily (recently around 5.8 million). Aurora Cannabis's SIR currently stands at 7.03. In other words for every 100,000 Aurora Cannabis shares traded daily on the market, roughly 7030 shares are currently held short.
However Aurora Cannabis's short interest can also be evaluated against the total number of Aurora Cannabis shares, or, against the total number of tradable Aurora Cannabis shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aurora Cannabis's short interest could be expressed as 0.2% of the outstanding shares (for every 100,000 Aurora Cannabis shares in existence, roughly 200 shares are currently held short) or 0.2042% of the tradable shares (for every 100,000 tradable Aurora Cannabis shares, roughly 204 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Aurora Cannabis.
Find out more about how you can short Aurora Cannabis stock.
We're not expecting Aurora Cannabis to pay a dividend over the next 12 months.
Aurora Cannabis's shares were split on a 1:12 basis on 10 May 2020. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aurora Cannabis shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Aurora Cannabis shares which in turn could have impacted Aurora Cannabis's share price.
Over the last 12 months, Aurora Cannabis's shares have ranged in value from as little as $3.71 up to $18.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aurora Cannabis's is 3.2254. This would suggest that Aurora Cannabis's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.